相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interruption of Autophagosome Formation in Cardiovascular Disease, an Evidence for Protective Response of Autophagy
Hany Khalil et al.
IMMUNOLOGICAL INVESTIGATIONS (2020)
The Controversial Role of Autophagy in Tumor Development: A Systematic Review
Bridilla Luiza Colhado Rodrigues et al.
IMMUNOLOGICAL INVESTIGATIONS (2020)
Methylomic Changes of Autophagy-Related Genes byLegionellaEffector Lpg2936 in Infected Macrophages
Ahmed Abd El Maksoud et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Regulation of Autophagy Progress via Lysosomal Depletion by Fluvastatin Nanoparticle Treatment in Breast Cancer Cells
Hanan Elimam et al.
ACS OMEGA (2020)
Targeted therapy for hepatocellular carcinoma
Ao Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The design and development of short peptide-based novel smart materials to prevent fouling by the formation of non-toxic and biocompatible coatings
Amutha Arul et al.
RSC ADVANCES (2020)
Guava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity
Hany Khalil et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Comparative Efficacy, Safety, and Costs of Sorafenib vs. Sunitinib as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Huan Deng et al.
FRONTIERS IN ONCOLOGY (2019)
Selective Regulation of B-Raf Dependent K-Ras/Mitogen-Activated Protein by Natural Occurring Multi-kinase Inhibitors in Cancer Cells
Ahmed I. Abd El Maksoud et al.
FRONTIERS IN ONCOLOGY (2019)
Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
Leonardo Gomes da Fonseca et al.
BMC CANCER (2018)
Sorafenib for the treatment of breast cancer
Giuseppe Bronte et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Single nucleotide polymorphisms of interleukins associated with hepatitis C virus infection in Egypt
Hany Khalil et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2017)
Identification of Novel and Efficacious Chemical Compounds that Disturb Influenza A Virus Entry in vitro
Hany Khalil et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
Awareness and current knowledge of breast cancer
Muhammad Akram et al.
BIOLOGICAL RESEARCH (2017)
New knowledge of the mechanisms of sorafenib resistance in liver cancer
Yan-jing Zhu et al.
ACTA PHARMACOLOGICA SINICA (2017)
The Mitogen-Activated Protein Kinase (MAPK) Pathway: Role in Immune Evasion by Trypanosomatids
Mercedes Soares-Silva et al.
FRONTIERS IN MICROBIOLOGY (2016)
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Mi Hee Park et al.
CELLS (2016)
Prediction of anticancer peptides against MCF-7 breast cancer cells from the peptidomes of Achatina fulica mucus fractions
Teerasak E-kobon et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)
Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials
Menelaos Zafrakas et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2016)
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
V. De Simone et al.
ONCOGENE (2015)
Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels
Jin-Hwan Kim et al.
EXPERIMENTAL CELL RESEARCH (2014)
A single NF kappa B system for both canonical and non-canonical signaling
Vincent Feng-Sheng Shih et al.
CELL RESEARCH (2011)
Synergistic activity of letrozole and sorafenib on breast cancer cells
Mara A. Bonelli et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Influence of NF-kappa B Signal-transduction Pathways on the Murine Inner Ear by Acoustic Overstimulation
Hiroshi Yamamoto et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress
KJ Cowan et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2003)
分享论文
